A Teratology Test System which Utilizes Postnatal Growth and Viability in the Mouse
The necessity of testing chemical agents for their potential to induce teratogenic effects has led to the establishment of standard teratology protocols (WHO, 1967; Health Protection Branch, 1977). These involve the exposure of pregnant animals to exogenous agents during the period of major embryonic organogenesis and the subsequent examination of the fetuses for soft visceral tissue and skeletal anomalies. These protocols are labor intensive and require highly trained personnel, factors which contribute to the considerable expense of such testing. A variety of potential screens, including developmental anomalies in invertebrates and lower vertebrates (Johnson, 1980; Davis et al., 1981), growth inhibition of mammalian cell cultures (Freese et al., 1979; Wilk et al., 1980), effects on organ culture (Kochar and Aydelotte, 1974), effects on cultured mammalian embryos (Kochar, 1975; Chatot et al., 1980), and in vivo embryotoxicity (Marhan and Jelinek, 1979), have been discussed as possible screens that would allow the prioritization of environmental agents for testing by standard methodologies. There have also been several excellent reviews of this general area in recent years (Wilson, 1978; Barrach and Neubert, 1980).
KeywordsLitter Size Sodium Selenite Teratogenic Effect Concurrent Control Sodium Salicylate
Unable to display preview. Download preview PDF.
- Chernoff, N., and E.H. Rogers. 1975. Proceedings of the Substitute Chemical Program: First Year of Progress, Volume II. Toxicological Methods and Genetic Effects Workshop, pp. 197–204.Google Scholar
- Health Protection Branch. 1977. The testing of chemicals for carcinogenicity, mutagenicity, and teratogenicity. Ministry of Health and Welfare, Canada.Google Scholar
- Hood, R.D., B.L. Patterson, G.T. Thacker, G.L. Sloan, and G.M. Szczech. 1979. Prenatal effects of 2,4,5-T, 2,4,5-trichlorophenol, and phenoxyacetic acid in mice. J. Environ. Sci. Health C13:189–204.Google Scholar
- Johnson, E.M. 1980. A subvertebrate system for rapid determination of potential teratogenic hazards. J. Environ. Pathol. Toxicol. 4:153–156.Google Scholar
- Kavlock, R.J., N. Chernoff, R. Baron, R. Linder, E. Rogers, and B. Carver. 1979. Toxicity studies with decamethrim, a synthetic pyrethroid insecticide. J. Environ. Pathol. Toxicol. 2:751–765.Google Scholar
- Kochar, D.M., and M.B. Aydelotte. 1974. Susceptible stages and abnormal morphogenesis in the developing mouse limb, analyzed in organ culture after transplacental exposure to vitamin A (retinoic acid). J. Embryol. Exp. Morphol. 31:721–734.Google Scholar
- Kochar, D.M. 1975. Assessment of teratogenic response in cultured postimplantation mouse embryos: effects of hydroxyurea. In: New Approaches to the Evaluation of Abnormal Embryonic Development. D. Neubert and H.J. Merker, eds. George Thieme: Stuttgart, pp. 250–277.Google Scholar
- Shepard, T.H. 1980. Catalogue of Teratogenic Agents. Johns Hopkins University Press: Baltimore.Google Scholar
- Wilk, A.L., J.H. Greenberg., E.A. Horigan, R.M. Pratt, and G.R. Martin. 1980. Detection of teratogenic compounds using differentiating embryonic cells in culture. In Vitro 16(4):269–276.Google Scholar
- Wilson, J.G. 1978. Review of in vitro systems with potential for use in teratogenicity screening. J. Environ. Pathol. Toxicol. 2:149–167.Google Scholar
- World Health Organization. 1967. Principles For the Testing of Drugs For Teratogenicity. WHO Tech. Rep. Series No. 364: Geneva.Google Scholar